Impact of Chromium, Phyllanthus Emblica, and Shilajit on Cardiovascular Health, Fitness, and Weight Loss During Exercise and Diet Programs
← catalyst calendarSponsored by Kerry Group P.L.C (industry) · KYGA.L — their whole pipeline →.
Phase
Not applicable
Status
Completed
Study type
Interventional
Design
Randomized · Triple · Other
Enrollment
112actual
Sites
1
Country
United States
Every value on this page is a field the sponsor filed with ClinicalTrials.gov, reproduced. Dates are their own estimates, revised as a study runs, unless the registry marks them actual. sources →
Source: ClinicalTrials.gov, retrieved 2026-08-25
Dates
each axis at the precision it was filed, with the registry's own basis| Date | Filed | Basis | What it is |
|---|---|---|---|
| Start | 2019-02-01 | actual | When the study began enrolling |
| Primary completion | 2024-01-30 | actual | The date the last participant is measured for the primary outcome — the readout window |
| Study completion | 2024-05-29 | actual | The whole study's end, after follow-up |
| First posted | 2024-10-15 | actual | When this record first appeared on the registry |
| Results posted | — | When the sponsor posted results to the registry | |
| Record updated | 2024-10-15 | actual | The sponsor's own last edit to this record — every projection above is as current as this date |
What it studies
Conditions
- Overweight
- Metabolic Syndrome X
Interventions
- Dietary supplement: Placebo
- Dietary supplement: Cr-400
- Dietary supplement: Cr-800
- Dietary supplement: PE-500
- Dietary supplement: PE-1000
Primary outcomes
what the primary-completion date above is the date OFFlow-Mediated Dilation (FMD)
measured Baseline, 6 and 12 weeks
Venous Occlusion (VO)
measured Baseline, 6 and 12 weeks
Platelet Aggregation
measured Baseline, 6 and 12 weeks
Fasting Glucose
measured Baseline, 6 and 12 weeks
HbA1c
measured Baseline, 6 and 12 weeks
C-reactive protein (CRP)
measured Baseline, 6 and 12 weeks
Lipid Profile-Cholesterol
measured Baseline, 6 weeks and 12 weeks
Lipid Profile -Triglycerides
measured Baseline, 6 weeks and 12 weeks
Lipid Profile- HDL Cholesterol
measured Baseline, 6 and 12 weeks
Lipid Profile- LDL Cholesterol
measured Baseline, 6 and 12 weeks
Lipid Profile- Calculated VLDL Cholesterol
measured Baseline, 6 and 12 weeks
Lipid Profile- Risk Ratio (LDL/HDL)
measured Baseline, 6 and 12 weeks
Lipid Profile- Risk Ratio (Cholesterol/HDL)
measured Baseline, 6 and 12 weeks
Publications
- PMID 40573153 — linked by the registry
Linked on the registry record. A “linked by the registry” entry is NLM's own automated PubMed match, not a claim by the sponsor that the paper reports this study.
Related
KYGA.L · their whole pipeline · Overweight readouts
KYGA.L's other studiesmost recently updated first
- Sleep Promoting Properties of a Botanical Extract in a Population Complaining From Non-Restorative Sleep (NRS) Not applicable · Recruiting
- Bacillus Coagulans Effect on Gastrointestinal Function in Healthy Adults. Not applicable · Completed
- Effect of Bacillus Subtilis ATCC 122264 Supplementation on Gas Symptoms and Quality of Life in Participants With Functional Bloating Not applicable · Completed
Permalink · KYGA.L's whole pipeline · Catalyst calendar · Every registered study · What changed